Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring

While most patients with chronic myeloid leukemia (CML) express either e13a2 or e14a2 BCR-ABL1 transcripts, a significant minority expresses variant transcripts, of which e19a2 is the most common. Although considered to have a relatively favourable outcome, reported responses to tyrosine kinase inhi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langabeer, Stephen E., McCarron, Sarah L., Kelly, Johanna, Krawczyk, Janusz, McPherson, Suzanne, Perera, Kanthi, Murphy, Philip T.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3420773/
https://ncbi.nlm.nih.gov/pubmed/22937329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/458716
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados